Chemotherapy or tyrosine kinase inhibitor for second line treatment in advanced non small cell lung cancer

被引：0
|
作者：
Jyoti, B. [1 ]
McKay, M. [1 ]
Wong, H. [1 ]
Alam, F. [1 ]
Eswar, C. [1 ]
Jain, P. [1 ]
Littler, J. A. H. [1 ]
Maguire, J. [1 ]
Schofield, C. P. [1 ]
Siva, A. [1 ]
Ramani, V. S. [1 ]
机构：
[1] Clatterbridge Ctr Oncol, Wirral, Merseyside, England
来源：
LUNG CANCER | 2012年 / 75卷
关键词：
D O I：
10.1016/S0169-5002(12)70019-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [21] The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Tucker, Steven
    CURRENT DRUG TARGETS, 2010, 11 (01) : 58 - 60
  • [22] Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment
    Ohtaki, Yoichi
    Shimizu, Kimihiro
    Suzuki, Hiroyuki
    Suzuki, Kenji
    Tsuboi, Masahiro
    Mitsudomi, Tetsuya
    Takao, Motoshi
    Murakawa, Tomohiro
    Ito, Hiroyuki
    Yoshimura, Kenichi
    Okada, Morihito
    Chida, Masayuki
    LUNG CANCER, 2021, 153 : 108 - 116
  • [23] EGFR TYROSINE KINASE INHIBITOR: CLINICAL EFFICACY IN ADVANCED NON SMALL CELL LUNG CANCER IN OUR SETUP
    Bhatnagar, Aseem R.
    Sharma, Rameshwaram
    Singh, Dharam P.
    Sharma, Om P.
    Sharma, Shantanu
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1215 - S1216
  • [24] Second-line treatment options in advanced non-small cell lung cancer
    de Marinis, Filippo
    Ricciardi, Serena
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S258 - S271
  • [25] Second line treatment with Camptothecins and Taxanes in advanced non-small cell lung cancer
    Kakolyris, S
    Georgoulias, V
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 183 - 189
  • [26] Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for thetreatment of advanced non-small-cell lung cancer
    Marquez-Medina, Diego
    Popat, Sanjay
    FUTURE ONCOLOGY, 2015, 11 (18) : 2525 - 2540
  • [27] Second-line chemotherapy for non-small cell lung cancer
    Ruckdeschel, JC
    CHEST, 2006, 129 (04) : 840 - 842
  • [28] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [29] Second line chemotherapy with carboplatin and gemcitabine in non small cell lung cancer
    Tassinari, D
    Arcangeli, V
    Panzini, M
    Oliverio, G
    Gianni, L
    Fochessati, F
    Passini, G
    Sartori, S
    Ravaioli, A
    ANNALS OF ONCOLOGY, 2000, 11 : 11 - 11
  • [30] Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience
    Caristi, N.
    Franchina, T.
    Proto, C.
    Chiofalo, G.
    Toscano, G.
    Scimone, A.
    Zanghi, M.
    Berenato, R.
    Briguglio, R.
    Denaro, N.
    Noto, L.
    Adamo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345